Mastering the Clinical Development of Personalized Cancer Medicines
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
Author:
Karen Honey, PhD
A string of innovative clinical trials designed to accelerate the pace at which personalized cancer medicines are developed have...
The rapid fire of U.S. Food and Drug Administration (FDA) approvals of new treatments for cancer continued last week...
Last week, the U.S. Food and Drug Administration (FDA) announced the first-ever approval of a treatment for Waldenström macroglobulinemia,...
A major question that researchers are trying to answer is: What links obesity with cancer development and adverse survival?
Cancer immunotherapy, which entered 2014 with the accolade of Science magazine’s Breakthrough of the Year for 2013, ended the...
Just before the holidays, the U.S. Food and Drug Administration (FDA) had good news for the ovarian cancer research...
Last week, the U.S. Food and Drug Administration (FDA) announced the approval of a new vaccine—Gardasil 9—that prevents infection...
Earlier this month we witnessed another leap forward for immunotherapy when the FDA approved blinatumomab (Blincyto) for the treatment...
Nina Bhardwaj, MD, PhD, co-chair of the AACR's special conference "Tumor Immunology and Immunotherapy: A New Chapter," discusses what...
Despite current screening efforts, colorectal cancer is the fourth most commonly diagnosed cancer worldwide and the fifth leading cause...